All In Biotech

Drug Trial Radar · NCT04963270

A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis

Last checked: Nov 20, 2026Latest source record: Feb 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 188 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

188

Actual

Start

Oct 19, 2021

Primary completion

Jan 29, 2024

Study completion Sep 2, 2024

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
Collaborators
Chugai Pharmaceutical
First posted
Jul 15, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of satralizumab compared with placebo in participants with generalized myasthenia gravis (gMG).

Conditions

  • Generalized Myasthenia Gravis

Interventions

  • SatralizumabDrug

    Satralizumab will be administered as a subcutaneous injection

  • PlaceboOther

    Satralizumab placebo will be administered as a subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. DB Period: Mean Change From Baseline in Total Myasthenia Gravis Activities of Daily Living (MG-ADL) Score in the AChR+ PopulationTime frame: At Week 24

Locations

76 sites in 17 countries. Site status is shown where the registry gives one.

  • Keck School of Medicine of USC

    Los Angeles, California

  • University of California Irvine - Manchester Pavilion

    Orange, California

  • SC3 Research Group, Inc

    Pasadena, California

  • Medical Faculty Associates Inc.

    Washington D.C., District of Columbia

  • University of Chicago Hospital

    Chicago, Illinois

  • Prairie Education and Research

    O'Fallon, Illinois

  • Hospital Italiano

    CABA, Argentina

  • Hospital Ramos Mejía

    CABA, Argentina

  • Hospital Britanico

    Ciudad Autonoma Bs As, Argentina

  • Fundación Scherbovsky

    Mendoza, Argentina

  • INECO Neurociencias Orono

    Rosario, Argentina

  • Concord Repatriation General Hospital

    Concord, New South Wales, Australia

  • Hospital Sao Lucas - PUCRS

    Porto Alegre, Rio Grande do Sul, Brazil

  • Hospital das Clinicas - UNICAMP

    Campinas, São Paulo, Brazil

  • Faculdade de Medicina do ABC - FMABC

    Santo André, São Paulo, Brazil

  • Hospital Sao Paulo

    São Paulo, São Paulo, Brazil

  • MUCH - Montreal Neurological Institute & Hospital

    Montreal, Quebec, Canada

  • Beijing Tongren Hospital

    Beijing, China

  • Beijing Tiantan Hospital,Capital Medical University

    Beijing, China

  • The First Hospital of Jilin University

    Changchun, China

  • West China Hospital - Sichuan University

    Chengdu, China

  • The Affiliated Hospital of Guizhou Medical University

    Guiyang, China

  • Sir Run Run Shaw Hospital

    Hangzhou, China

  • The First Affiliated Hospital Of Shandong First Medical University

    Jinan, China

  • Huashan Hospital, Fudan University

    Shanghai, China

  • Children's Hospital of Fudan University

    Shanghai, China

  • Tianjin Medical University General Hospital

    Tianjin, China

  • Tongji Hospital Tongji Medical College Huazhong University of Science and Technology

    Wuhan, China

  • Tangdu Hospital

    Xi'an, China

  • Aarhus Universitetshospital

    Aarhus N, Denmark

  • Rigshospitalet

    København Ø, Denmark

  • CHU Bordeaux

    Bordeaux, France

  • APHP Raymond Poincare

    Garches, France

  • Hopital Timone Adultes

    Marseille, France

  • CHU de Nantes - Hotel Dieu

    Nantes, France

  • CHU Nice - Hôpital Pasteur 2

    Nice, France

  • St. Josef-Hospital, Klinik für Neurologie

    Bochum, Germany

  • Universitätsklinikum Essen (AöR)

    Essen, Germany

  • Universitätsklinikum Münster

    Münster, Germany

  • Azienda Ospedaliera A. Cardarelli

    Naples, Campania, Italy

Showing 40 of 76 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.